| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.00021 | 1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.00012 | 1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -5.5e-05 | 1 |